Promoter holding
64.27%
CD
Cryogenex Diagnostics Private Limited - Due diligence report
A 360° intelligence report on Cryogenex Diagnostics Private Limited: trust score, financial health, credit view, compliance, directors, grow…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹349
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Cryogenex Diagnostics Private Limited — 360° Intelligence Report
Generated from MCA filings & public records72/100
Trust Score
Moderate
Cryogenex Diagnostics Private Limited is assessed as Moderate with a Trust Score of 72/100. Cryogenex Diagnostics Private Limited is an active private limited indian non-government company incorporated in 2010, operating in the Healthcare sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.
Report generated on 09 Jul 2026 from the latest processed filings. Cryogenex Diagnostics Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
72/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
48/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 4 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- No open charges - unencumbered balance sheet.
- Profitable - internal accruals available.
Charges position: 0 open (-) · 0 satisfied (-).
Compliance Score: 48/100 Caution Indicated
- Company status is Active as per MCA.
- Marked ACTIVE non-compliant (INC-22A).
- Last balance sheet is for Mar 2019 - filings overdue.
- Litigation present in 1 court forum(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| PARBATI PALATA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MANORANJAN PRADHAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2015)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2017 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 50 · Distress 60
Growth signals & trust indicators
Latest year revenue grew 1.42.
Operating for 15+ years.
Distress signals & risk flags
Profit declined two years in a row.
Outside liabilities up 2.1x in a year.
Statutory filings appear overdue.
Compliance score is weak (48/100).
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence59/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 3 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment76/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
Investor view68/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 1 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 13 events01 Jun 2022
Director ceased
RAJKISHORE ABHIRAM MALLICK
31 May 2022
Director ceased
SAILABALA PAIKARAY
30 Sep 2019
Last AGM held
Annual general meeting
31 Mar 2019
Latest balance sheet
Filed with ROC
28 Mar 2019
Director appointed
MANORANJAN PRADHAN (Director)
19 Jul 2018
Director ceased
NIRANJAN SAHOO
Director ceased
KUNTALA SWAIN
22 Dec 2015
Director ceased
SANJAY SWAIN
Director ceased
RADHAKRISHNA SAHOO
04 Aug 2015
Director ceased
RANJIT KUMAR MOHANTY
27 Feb 2012
Director ceased
MANORANJAN PRADHAN
10 Sep 2010
Incorporated
Registered with Roc Jammu
Director appointed
PARBATI PALATA (Director)
10
Key Observations
Auto-generated from the data aboveRevenue declined 24% over the last 3 financial year(s).
Net profit margin moved from 0.86 to 61%.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
| Company | CIN | Location |
|---|---|---|
| Nallatesh Wellness Services Private Limited | U85100MH2018PTC312115 | Navi Mumbai, Maharashtra, India |
| Vedicus Healthcare Private Limited | U85100HR2015PTC057582 | Yamuna Nagar, Haryana, India |
| Anuseva Health Care Private Limited | U85190TN2013PTC093927 | Chennai, Tamil Nadu, India |
| Star Life Sciences Private Limited | U24230TZ2012PTC018211 | Hosur, Tamil Nadu, India |
| Pace Medical Systems Private Limited | U51397KL2005PTC018324 | Trivandrum, Kerala, India |
| Stosswelle Healthcare Private Limited | U85100MH2010PTC210496 | Mumbai, Maharashtra, India |
| Waft Pharma | U33100AP2017PTC106922 | Rajamahendravaram, Andhra Pradesh, India |
| Cudure Healthcare Private Limited | U74900AP2016PTC098180 | Vishakapatanam, Andhra Pradesh, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Cryogenex Diagnostics Private Limited before audits and certifications: compliance score 48/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Cryogenex Diagnostics Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Cryogenex Diagnostics Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 72/100, distress signals and MSME payment-delay disclosures - know whether Cryogenex Diagnostics Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Cryogenex Diagnostics Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Cryogenex Diagnostics Private Limited an active company?
Cryogenex Diagnostics Private Limited has MCA status “Active” with a compliance score of 48/100 (Caution Indicated).
Is Cryogenex Diagnostics Private Limited financially healthy?
Cryogenex Diagnostics Private Limited has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.
Should I do business with Cryogenex Diagnostics Private Limited?
Its overall Trust Score is 72/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Cryogenex Diagnostics Private Limited?
See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.
Does Cryogenex Diagnostics Private Limited have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Cryogenex Diagnostics Private Limited up to date with its ROC filings?
Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 48/100 (Caution Indicated).
Is it risky to lend to Cryogenex Diagnostics Private Limited?
Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
